Global Gummy Vitamins Market Catering to Children with Deliciousness

While rural communities lack the awareness and infrastructure, urban populations are failing to intake balanced diet owing to ill-eating habits driven by restless lifestyle. Both these masses are potential consumers for the market of gummy vitamins, which have emerged as strong alternative to nutrition supplements that must be taken to avoid various vitamin-deficiency diseases. Gummy vitamins are easy to be fed to children, help in filling nutritional gaps, and prompts adults to take their vitamins without smelling burps. A recent business and commerce study by Transparency Market Research (TMR) has observed that vitamin deficiency diseases such as blindness, beriberi, pellagra, scurvy, and rickets are highly prevalent across the world and consequently, the demand in the global gummy vitamins market will expand at a healthy CAGR of 5.2% during the forecast period of 2017 to 2025. The report has estimated that the opportunities in the global gummy vitamins market will reach a valuation of US$4.17 bn by the end of 2025, significantly up from its evaluated worth of US$2.68 bn in 2016.

Which factors will ensure a prosperous future of gummy vitamins market?

Ubiquity of smartphones has given strong traction to social media, which in turn has radically increased the awareness among large masses regarding the need for supplements such as vitamin A, C, E, and K on a routinely basis. As the trend of healthy living and fitness spreads among larger populations, people are quickly shifting towards gummy vitamins instead of capsules. Same delicious benefits, along with availability in different taste, shape, and color, has helped children consuming their supplements. In addition to that, owing to their structure, gummy vitamins are digested and absorbed quicker than traditional alternatives. These all factors are expected to favor the prosperity of the global gummy vitamins market in the near future.

Which market segments are poised for stronger growth?

Product-wise, the TMR report segments the global gummy vitamins market into single vitamin, which is further sub-segmented into Omega & DHA, Vitamin C, Biotin, Vitamin D, CoQ10, Melatonin, High-fiber Formulas, and others, and multivitamins. Out of these, currently, the multivitamins segment serves the maximum demand, which is a reflection of development of new formulations in taste and shape. With the availability of advanced pathology practices, consumers are now well aware of their deficiencies, which can be multiple most times, and prefer taking compounds that makes up for digesting individual pills. That being said, the single vitamin segment is also gaining favor among population who only have one vitamin deficiency.

Which geographical region is showing most potential?

As per the projections of the TMR report, the demand in the North America gummy vitamins market will expand at a CAGR of 5.0% during the forecast period of 2017 to 2025, with the revenue expected to reach US$1.64 bn by 2025. At the second position in terms of demand for gummy vitamins is the region of Europe, which is anticipated to serve a demand worth of US$741 mn by 2025.

What is the nature of competitive landscape?

Bayer AG currently leads the global gummy vitamins market, dominating via its diverse product portfolio that targets consumers of all ages, higher allocation on product development, and strong supply chain model. Some of the other prominent vendors of this market are: Boli Naturals LLC, ABH Labs, LLC, F. Hunziker + Co AG, Vitakem Nutraceutical Inc., Gimbal Brothers, Inc., Ferrara Candy Company, Ernest Jackson, Melrob Group, Santa Cruz Nutritionals, Makers Nutrition, LLC, Nutra Solutions USA, Contract NUTRA, Softigel, and Sirio Pharma.

Reduced Cost of Operation and Increased Production Capacity to Fuel Growth of Pharmaceutical Continuous Manufacturing Market

Pharmaceutical continuous manufacturing requires less manual intervention and are thus gaining popularity. Using this technology, active ingredients are produced in compact and closed units, leveraging automation. Pharmaceutical continuous manufacturing helps in bringing about continued utilization of production capacity, which in turn improves yield, decrease fluctuations in the production process, and therefore results in reduced cost of operation. The advantages of this manufacturing process are increasingly being realized and this leading to rapid adoption of pharmaceutical continuous manufacturing, boosting its market worldwide. A leading market research firm Transparency Market Research (TMR) estimates that the global pharmaceutical continuous manufacturing market will rise from US$1.74 bn in 2016 to be worth US$3.693 bn by 2025, exhibiting a CAGR of 8.8% from 2017 to 2025.

The expert market analysts from TMR answer three important questions pertaining to this market in the following blog post:

Q. What are the factors driving the growth of the global pharmaceutical continuous manufacturing market?

The superior development speed of pharmaceutical continuous manufacturing technology is one of the key reasons boosting their adoption. This technology ensures enhanced process safety when handling hazardous chemicals. Pharmaceutical continuous manufacturing technology also gives an opportunity to perform reactions which cannot be done in batch processing. All these factors are anticipated to fuel the growth of this market across the globe. The growing incidences of various diseases and thus, the heightened demand for treatment are also expected to drive the growth prospects of this market. pharmaceutical continuous manufacturing technology is slated to succeed on account of the maturing of a mix of sophisticated technologies which is resulting in automation, better equipment and accurate monitoring.

Q. Which region is anticipated to emerge most attractive in the pharmaceutical continuous manufacturing market in the years to come?

Of the key geographical areas such as Latin America, North America, Europe, Asia Pacific, and the Middle East and Africa, Europe is currently leading with maximum shares. Europe accounted for over 35% of the total market in 2016 on account of the escalating demand for superior technology from contract manufacturing organizations and pharmaceutical companies. It is also estimated that Europe will continue to lead and hold its position in the market for the years to come. In addition to this, the European market for pharmaceutical continuous manufacturing will expand at a rapid pace and be the fastest growing regional market too. The availability of advanced technologies and increasing number of technology providers are expected to be key reasons for the growth of this market.

Request and Download Sample Report@

Q. Which application segment is leading in the global pharmaceutical continuous manufacturing market?

Of the key application segments of the global pharmaceutical continuous manufacturing market such as dry powders, biologics, and active pharmaceutical ingredients, the market for biologics is leading. In the year 2016, the biologics segment accounted for over 35.3% of the market. The pharmaceutical ingredients segment was in second position in 2016. This trend is likely to continue in the coming years. 

Life Science Microscopy Devices to Witness Notable Growth Due to its Exceptional Operational Capabilities

The global life science microscopy devices market is foreseen to witness a significant rise in the coming years. There are several microscopes in the market for various purposes and with operational abilities. Optical microscopes for example phase contrast, stereo microscopes, and fluorescence microscopes work on the phenomenon of reflection of lights. Another type of microscope which work on electron beam properties in order to reflect and magnify the images and electron microscope. Such various purposes of microscopes in different fields have contributed in the steady growth of the life science microscopy devices market. As per the report by Transparency Market Research (TMR) the global demand for life science microscopy devices is likely to soar with a moderate CAGR of 6.5% within the forecast period from 2016to 2024, with the expected worth of US$ 2.0 bn by the end of 2024. The value of the concerned market in year 2015 was evaluated to be worth US$ 1.1 bn.

What outstanding features and applications drive the life science and microscopy devices market?

Due to the emergence of usage in various sectors such as material science, semiconductors technology, nanotechnology, and other life science sectors, the surge in demand for microscopy devices is anticipated to grow as well. New and propelled microscopic instruments are being launched in the market which are empowering specialists around the globe to go down at minute and detailed levels, and examine the cells, materials, and with high accuracy and 3D imaging services. Moreover, with the advancement in technology with advent of integrated microscopes furnished with all the fundamental and extra features, for example, high resolution camera, imaging instruments and technique such as Raman spectroscopy, and several other features are relied upon to drive the development of the microscopy gadgets in the life science field. Howbeit, due to emergence of lot of players in the market there has been a significant rise in the competition in the market. This is likely to hamper the market growth in the coming years.

Which segment dominated the market due to its varied usage in the global market?

On the basis of device type, the global life science microscopy devices market is broadly segmented into electron microscopes, scanning probe microscopes, and optical microscopes. However, the market was analyzed to be dominated by optical microscope in year 2015. This segment comprises of inverted microscopes, near field scanning microscopes, fluorescence microscopes, phase contrast microscopes, confocal scanning microscopes, stereo microscopes, and several other varieties of microscopes. The growing demand of microscopes in developing countries, especially in healthcare industry including clinics, laboratories, pathology, toxicology and pharmacology applications are also adding up to the growth in the market.

What factors fueled up the growth of microscopy devices in North America Market?

Apart these, based on geographical regions, the market is segregated into Asia Pacific, Latin America, Europe, North America, and the Middle East and Africa. North America reigned the microscopy devices market in 2015 accounting 47.3% of the entire market shares. The major reason behind this surge is the increase in funding provided for the research and development in life science and biomedical department. This factor is expected to keep on fueling the region’s growth in coming year as well. Europe is following the race, where it emerged as the second leading region in the market in the following year. Nonetheless, Asia Pacific Market is foreseen to surpass all the region and dominate the entire global market for life science microscopy devices holding a steady CAGR in coming years.

Some of the key players in the industry are Nikon Corporation, JOEL Ltd., Hitachi High-Technologies Corporation, Carl Zeiss Microscopy GmBH, NT-MDT, Olympus Corporation, Bruker Corporation, FEI Company, Leica Microsystems, and Cameca SAS. Each of them is striving to develop more precise and accurate products to sustain their market position, along with providing customer satisfaction and being easy on pockets as well.

Demand for Gummy Vitamins to Soar as Cases of Under-nourished Children Increase

Among children, gummy vitamins have gained much popularity as this product was pitched as a good alternative to bitter pills. Now however, adults who are health conscious and wish to have better life expectancy are also consuming gummy vitamins. This has resulted in the growth of the global gummy vitamins market. Growing number of cases where people are under nourished and increasing number of children suffering from malnutrition specially in developing nations will also help escalate the demand for gummy vitamins. According to Transparency Market Research (TMR), the global gummy vitamins market is anticipated to rise from US$2.68 bn in 2016 to US$4.17 bn by 2025, expanding at a 5.2% CAGR between 2017 and 2025.

In the following blog post, expert market analysts from TMR answer three important questions regarding the global gummy vitamins market:

Q. Which type of gummy vitamin will be more in demand?

Gummy vitamins are of two types single and multi vitamins. Of these, the demand for multivitamins is much more on account of the growing popularity of these supplements and the development of new formulations, which have improved taste and shape. Multi-vitamins are gaining comprehensive supply chain and distribution management of nutritional supplement. In the years to come, it is expected that companies will have superior production facilities all across the globe and offer innovative products. In the years to come, the single vitamin segment will also witness healthy growth on account of the growing demand for Vitamin D supplements across people belonging to all age groups. Also, the growing usage of omega-3 DHA among pregnant women will push the growth of the single vitamin market.

Q. Which regional segment will witness maximum demand for gummy vitamins?

The high uptake of dietary supplement among the health conscious adults as well as old age people wishing to up their daily nutrient intake have led to North America being the leader in teh global gummy market. Others factor fueling the growth of the market are high disposable income of the people and the growing number of product developments by key and keen players. North America is anticipated to expand at a 5% CAGR from 2017 to 2025 and be worth US$1.64 bn by 2025. Europe is anticipated to be the second leader in the gummy vitamins market after North America. The European market will be worth US$741 bn by 2025, driven by a strong demand for this product as well as innovations in the gummy vitamin formulations. The factor that is restricting the growth of the gummy vitamins market is the stringent regulations regarding these supplements in Europe.

Request and Download Sample Report@

Q. Which factors will restrict the growth of the global gummy vitamins market?

The side effects relating to the overconsumption of gummy vitamins is a major challenge which is hampering their demand and the reason why people are refraining from consuming them. Also, several nations in the world have strict regulations that limit the consumption of gummy vitamins. In the under-developed or developing economies, the awareness about the benefits of gummy vitamins is low. This is also acting as a growth impeder. The risks associated with daily consumption of any vitamin are creating negative publicity and this will deter many people to seek alternative ways to healthy and balanced diet and lifestyle.

Prevailing Cases of Infertility to Fuel the Demand for In-Vitro Fertilization in the Global Market

The boost in the demand for global in-vitro fertilization market can be credited to the growing number of cases with infertility in both men and women since past few years. According to a recent report by Transparency Market Research (TMR) the global market for in-vitro fertilization is anticipated to demonstrate a steady and flourishing growth in coming years. It is foreseen to hold a strong CAGR of 6.5% within its forecast period from 2017 to 2022. In year 2017 the market was evaluated to be worth US$ 29.8 mn. This figure is likely to soar around worth US$ 725.9 mn by the end of forecast period 2022. The rising predominance of infertility due to lifestyle-induced components, combined with the inclination of couples to defer family planning, has highlighted the interest for IVF in different developed and developing regions. The maintained concentration to address the developing worries of male infertility all around the world, fundamentally disturbed by hereditary elements, has reinforced the interest for IVF as of late.

Change in Lifestyle to be Responsible for the Growth of In-Vitro Fertilization Technology

The rising number of couples, men or ladies, enduring with different anatomic factors, for example, endometriosis and tubal illness, ovulatory ailments, and unexplained instances of infertility in different parts of the world is a key pattern feeding the interest for in-vitro fertilization medications. The commonness of infertility can be credited to an amalgamation of elements, for example, hereditary, unprotected intercourse, and way of life actuated. However, the danger of fizzled IVF cycle is a key factor liable to obstruct the market. Then again, late headway in advancements and the developing mastery of clinicians are factors anticipated that would address this worry.

The expansion in the quantity of known hereditary issue in developed countries among ripe couples likewise looks good for the in-vitro treatment market. These couples choose IVF to keep the transmission of the illnesses to their children. The wide accessibility of hereditary tests in various propelled countries is foreseen to additionally support the recognition of these hereditary issue, consequently powering the interest for IVF systems. The accessibility of routine protection scope for IVF methodology is picking up footing in a few created and creating nations, which is required to open up lucrative market roads. This is additionally anticipated that would cut down the cost of treatment.

Asia Pacific to Witness a Significant Growth in the Market Demand for IVF

The major regional market is segmented into North America, Middle East and Africa, Europe, Asia Pacific, Latin America, and Japan. Of these, the Asia Pacific holds the significant income of the worldwide market in 2017 and is relied upon to hold its predominance in coming years as well. Ascending at a CAGR of 6.7%, the regional in-vitro fertilization market will achieve a value US$235.9 mn before the finish of the conjecture time frame. The strength is ascribed to ideal government activities and a thriving healthcare tourism in a few developing countries. The North America in-vitro fertilization market is anticipated to ascend from US$141.3 mn in year 2017 to worth US$196.1 mn before the end of year 2022. The regional market is expected to ascend at a noteworthy CAGR of 6.8% amid the forecast period. Consistent progressions made in IVF advancements and developing protection scope are key variables highlighting the local market. Besides, the development is probably going to be filled by rising rate of infertility in the region.

Request and Download Sample Report@

Europe to Lose its Interest Rate in Terms of Revenue in Coming Years

In the interim, Europe in-vitro fertilization market is also anticipated to lose somewhere in the range of 44 BPS between 2017 and 2022. By 2017 end, the worldwide share of the local market is evaluated at 19.9%, in terms of revenue. Cook Medical, Vitrolife AB, CooperSurgical, EMD Serono, Inc., Genea Ltd., Fertility Focus Ltd., Thermo Fisher Scientific, Inc., Merck KGaA, Ovascience, Inc., Rocket Medical PLC, are some of the leading firms reigning the global in-vitro fertilization market.

Improved Healthcare Services to Boost the Market Demand for Dermatology Diagnostic Devices and Therapeutics

The global dermatology diagnostic devices and therapeutics market is prognosticated to witness a tremendous growth in coming years. Several key players are likely to work on expanding their distribution networks and geographical outreach to come up with more innovative solutions in coming times and also to remain competitive in the market. As per the report by Transparency Market Research (TMR) the global demand for dermatology diagnostic devices and therapeutics is anticipated to lead its market value to be around US$ 21.0 bn by the end of 2024. This value was evaluated to be worth US$ 18.5 bn in the year 2015. Moreover, the global dermatology diagnostic devices market is expected to showcase a healthy growth with a strong CAGR of 7.1% within the forecast period from 2016 and 2024. This market was evaluated to be worth US$ 595.6 mn in the past, which is likely to reach around US$ 1,095.1 mn in coming years. By far, the dermatology therapeutics market is foreseen to be a dominant one among both the components with the evaluated worth of US$ 20 bn by the end of forecast period.

How air pollution is being the major reason for the rise in demand for dermatology diagnostic devices and therapeutics?

The rising problems in terms of air pollution in developed economies is one of the key drivers for the global dermatology diagnostic devices and therapeutics market. The high prevalence of air contamination has prompted an unfaltering increment in the emergence of dermatological conditions and is probably going to be assumed a key part in the rising demand for the dermatology diagnostic devices and therapeutics market in the coming time because of the quick pace of urbanization and industrialization over the world. Apart this, the rise in the number of geriatric population is likewise prone to help development of the global dermatology diagnostic devices and therapeutics market in the coming times as well. Not just that, but anti-ageing products also include as a vital element of the cosmetic industry worldwide and are probably going to contribute altogether to the dermatology diagnostic devices and therapeutics market in the coming years.

The high predominance of skin issue and conditions has brought alerts up in the field of dermatology, clearing route for an extensive variety of dermatology diagnostic devices and therapeutics. Skin conditions, for example, rosacea, cell carcinoma, skin inflammatory disease - eczema, skin break out, pruritus, dermatitis, and psoriasis among others have made a smooth pathway for the development of dermatology diagnostic devices and therapeutics. The global market is likewise prone to be driven by rising interests in the innovative work of novel dermatology therapeutics as well.

What are the dominating segments in dermatology diagnostic devices and therapeutics market supporting the overall growth?

On the basis of drug class the global dermatology diagnostic devices and therapeutics market is segmented into retinoids, antibacterial agents, antifungal agents, corticosteroids, biologics, immunosuppressants, and antiviral agents. If reports are followed then the antibacterial drugs segment is anticipated to lead the market in coming years with a growing CAGR of 3.3% within the forecast period. The imaging division is further divided into ultrasound, optical coherence tomography (OCT), X-ray, magnetic resonance imaging (MRI), and others.

What factors make North America region to lead the race among other regions?

As per the geographical regions, North America is anticipated to lead the global market as it held a major section of share of 43.8% in the global market in the year 2014. The simple availability to healthcare services, and high awareness about skin diseases, reasonable healthcare facilities are anticipated to drive the local market. The North America dermatology diagnostic devices and therapeutics market is likewise observe a breathtaking ascent as the region has a solid nearness of pharmaceutical organizations and incredible repayment approaches. Asia Pacific and Europe, then again, are relied upon to witness a spurt of development also in coming years. The expanding use on medicinal services in the developing economies is relied upon to be critical to the market development in this region.

Dino-Lite Europe/IDCP B.V., Agfa-Gevaert N.V., Genentech, LEO Pharma A/S, Michelson Diagnostics Ltd., Novartis International AG, Astellas Pharma, Inc., Cutera, Inc., Galderma S.A., Valeant Pharmaceuticals International, Inc. are some of the leading firms in the global dermatology diagnostic devices and therapeutics market. 

Ubiquity of Smartphones Driving Global NFC Chips Market

Near field communication (NFC) chips, or the technology as a whole, has emerged as something very useful that can be used in laptops, smartphones, and tablets for a data exchange over a short range of about 10cm or less. NFC chips are an array of protocols based over a wireless interface that works with electronic gadgets and other communication devices to establish radio communication when in proximity. On account of the convenience and versatility that NFC chips offer, the market for the same has expanded quickly as these chips can help in enhancing safety. In addition to that, the growing need for secure transactions can be felt worldwide and this is boosting the growth of the NFC chips market. NFC requires PIN and does not provide retailers with credit card information about users and thus, more secure. 

A recent business and commerce study by Transparency Market Research reiterates the expanding demand for NFC chips, projecting the revenue in the market to increment at an impressive CAGR of 26.0% during the forecast period of 2016 to 2024. The report has evaluated that the opportunities in the global NFC chips market were worth US$1.35 bn in 2015, which will exponentially rise up to US$10.62 bn by the end of 2024.

Which factors are favoring the global NFC chips market?

Growing adoption of smart appliances, trend of mobile commerce, growth in the production of NFC chips and mobile phones, enhanced user experience and trust in contactless technologies, and decline in the prices of these chips are some of the key factors augmenting the demand in the global NFC chips market. On the other hand, inability of these chips to expand to longer range communications, lack of consumer awareness (especially in the rural areas of emerging economies), lack of proprietary standards, disagreement and disputes between key players in the value chain, and need for intermediaries gateway for mobile payment are a few challenges that are obstructing the prosperity of the NFC chips market. Nevertheless, the vendors operating in this market will continue to gain new opportunities from integrated ICS supporting NFC, Wi-Fi, and Bluetooth, growing need for connectivity between different devices, and online and in-store payment.

Which market segments are showing greater promise?

Application-wise, the TMR report segments the global NFC chips market into television, smartphones, car, medical equipment, and others. Currently, the segment of smartphones has been providing the maximum demand in the NFC market. Rapid ubiquity of smartphones and growing adoption of newer technologies is aiding the prosperity of this segment. The medical equipment and television segments are not far behind in terms of growth. The increasing disposable income of consumers worldwide will lead to a healthy growth of the television segment.

Geographically, the report picks out North America as most lucrative region for the vendors operating in the NFC chips market, wherein 34% of the demand came in 2015. However, Asia Pacific is anticipated to emerge as the dominant regional market for NFC chips by the end of the forecast period. The APAC NFC chips market is estimated to expand at an above-average 27.90% CAGR between 2016 and 2024 on account of the growing penetration or use of smart phones in the region.

What is the nature of competition among the leading companies?

NXP Semiconductor dominated the global NFC chips market in 2015, reserving 55% of the market shares, and the company is expected to retain its position of strength by the end of 2022. Qualcomm Inc., STMicroelectronics, Broadcom Corp., Texas Instrument, and AMS AG are some of the key prominent companies operating in this market.

Latest Post

Market Research Reports